Inventor · disambiguated record
Richard H. Weisbart
Also filed as: WEISBART RICHARD · WEISBART RICHARD H
27 granted patents·13 pending applications·265 citations·filing 1987–2024
96Inventor score
Top patents by PatentIndex Score
40 records- 0196US7189396B1Delivery system using mAb 3E10 and mutants and/or functional fragments thereofUS DEPT VETERANS AFFAIRS·Filed 2002·Granted Mar 13, 2007·80 cites·10 claims
- 0291US9701740B2Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repairHANSEN JAMES E·Filed 2012·Granted Jul 11, 2017·12 cites·32 claims
- 0388US10683363B2Targeting intracellular target-binding determinants with intracellular antibodiesUS VETERANS AFFAIRS·Filed 2016·Granted Jun 16, 2020·5 cites·14 claims
- 0487US9283272B2Targeting intracellular target-binding determinants with intracellular antibodiesWEISBART RICHARD H·Filed 2013·Granted Mar 15, 2016·5 cites·4 claims
- 0586US9732146B2Antibody-mediated transduction of heat shock proteins into living cellsNISHIMURA ROBERT N·Filed 2013·Granted Aug 15, 2017·6 cites·18 claims
- 0686US4812397AMAB-anti-DNA related to nephritisUNIV CALIFORNIA·Filed 1987·Granted Mar 14, 1989·60 cites·22 claims
- 0785US12116416B2Targeting intracellular target-binding determinants with intracellular antibodiesUS GOV VETERANS AFFAIRS·Filed 2023·Granted Oct 15, 2024·0 cites·5 claims
- 0885US9155801B2Amino acid sequences which enhance peptide conjugate solubilityWEISBART RICHARD H·Filed 2010·Granted Oct 13, 2015·6 cites·14 claims
- 0985US8956825B2Intranuclear protein transduction through a nucleoside salvage pathwayWEISBART RICHARD H·Filed 2008·Granted Feb 17, 2015·8 cites·15 claims
- 1083US10961301B2Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repairUNIV YALE·Filed 2017·Granted Mar 30, 2021·1 cites·20 claims
- 1183US10238742B2Cell penetrating nucleolytic antibody based cancer therapyUNIV YALE·Filed 2015·Granted Mar 26, 2019·3 cites·12 claims
- 1283US2024247056A1Cell-penetrating anti-dna antibodies and uses thereof inhibit dna repairUNIV YALE·Filed 2024·Application pending·0 cites
- 1382USRE46211EDelivery system using MAB 3E10 and mutants and/or functional fragments thereofWEISBART RICHARD·Filed 2009·Granted Nov 22, 2016·6 cites·12 claims
- 1481US12479925B2Targeting intracellular target-binding determinants with intracellular antibodiesUS GOV VETERANS AFFAIRS·Filed 2023·Granted Nov 25, 2025·0 cites·21 claims
- 1580US2023077885A1Methods for dna-dependent targeting of a cell permeant antibodyUS GOV VETERANS AFFAIRS·Filed 2022·Application pending·0 cites
- 1678US10383945B2Methods for DNA-dependent targeting of a cell permeant antibodyUS VETERANS AFFAIRS·Filed 2016·Granted Aug 20, 2019·1 cites·20 claims
- 1778US9133460B2Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subjectWEISBART RICHARD H·Filed 2014·Granted Sep 15, 2015·1 cites·1 claims
- 1877US10040867B2Cell penetrating anti-guanosine antibody based therapy for cancers with Ras mutationsUNIV YALE·Filed 2015·Granted Aug 7, 2018·3 cites·35 claims
- 1977US8680066B2Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subjectWEISBART RICHARD H·Filed 2012·Granted Mar 25, 2014·1 cites·17 claims
- 2071US11453725B2Methods for DNA-dependent targeting of a cell permeant antibodyUS VETERANS AFFAIRS·Filed 2019·Granted Sep 27, 2022·0 cites·40 claims
- 2170US2022017609A1Cell-penetrating anti-dna antibodies and uses thereof inhibit dna repairUNIV YALE·Filed 2021·Application pending·0 cites
- 2269US2020129636A1Methods for dna-dependent targeting of a cell permeant antibodyUNIV YALE·Filed 2019·Application pending·0 cites
- 2368US12195550B2Targeting intracellular target-binding determinants with intracellular antibodiesUS VETERANS AFFAIRS·Filed 2020·Granted Jan 14, 2025·0 cites·2 claims
- 2465US6090380ATreatment of rheumatoid arthritis by oral administration of pooled human immunoglobulinRES CORP TECHNOLOGIES INC·Filed 1995·Granted Jul 18, 2000·15 cites·6 claims
- 2565US5034316AIn vitro human monoclonal IgG rheumatoid factor autoantibodyUNIV CALIFORNIA·Filed 1987·Granted Jul 23, 1991·27 cites·3 claims
- 2664US10703807B2Antibody-mediated transduction of heat shock proteins into living cellsUS GOV VETERANS AFFAIRS·Filed 2017·Granted Jul 7, 2020·0 cites·19 claims
- 2758US10702543B2Intranuclear protein transduction through a nucleoside salvage pathwayUS GOV VETERANS AFFAIRS·Filed 2015·Granted Jul 7, 2020·0 cites·5 claims
- 2857US2010143358A1Use of Antibody ConjugatesUS DEPT VETERANS AFFAIRS·Filed 2008·Application pending·0 cites
- 2957US2020199255A1Multivalent fragments of antibody 3e10 and methods of use thereofUNIV YALE·Filed 2019·Application pending·0 cites
- 3056US2013259862A1Antibody-mediated transduction of heat shock proteins into living cellsNISHIMURA ROBERT N·Filed 2013·Application pending·0 cites
- 3154US2019307883A1Cell penetrating nucleolytic antibody based cancer therapyUNIV YALE·Filed 2019·Application pending·0 cites
- 3251US2004180045A1Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin GFiled 2004·Application pending·0 cites
- 3350US5252461AMixed immunoglobulins for detection of rheumatoid factorsUNIV CALIFORNIA·Filed 1992·Granted Oct 12, 1993·15 cites·9 claims
- 3450US2017096497A1Use of antibody conjugatesUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 3547US6232444B1Conserved anti-DNA antibody idiotype associated with nephritis in murine and human lupusUNIV CALIFORNIA·Filed 1996·Granted May 15, 2001·4 cites·6 claims
- 3645US6200565B1Oral administration of immunoglobulins for treating autoimmune hearing lossRES CORP TECHNOLOGIES INC·Filed 1999·Granted Mar 13, 2001·5 cites·10 claims
- 3745US2002098182A1Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin GFiled 2001·Application pending·0 cites
- 3840US2017291961A1Multivalent fragments of antibody 3e10 and methods of use thereofUNIV YALE·Filed 2015·Application pending·0 cites
- 3939US2003099635A1Use of oral gammaglobulin for the treatment of immune-mediated diseasesPROTEIN THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 4030US5238851AMixed immunoglobulins for detection of rheumatoid factorsUNIV CALIFORNIA·Filed 1991·Granted Aug 24, 1993·1 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Richard H. Weisbart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →